Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.42%, EPS grew 43.1%, free cash flow grew 14.1% and total debt fell 9.88%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.

294.66 1.43 +0.49%
Market cap
$112.5B
P/E
30.3×
Fwd P/E
24.1×
Dividend yield
1.19%
F-score
5/9
Altman Z
4.81
Beneish M
−2.62
Dividend safety
82/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
16.51% 15.20% 15.08% 14.04%

+8 more TTM periods

Piotroski F-Score
7 7 5 4
ROA
7.91% 7.23% 7.15% 6.48%
ROIC
9.76% 8.97% 8.94% 6.54%
Return on Tangible Assets
31.89% 30.59% 29.95% 29.34%
Average Days of Receivables
52.88 51.58 58.70 54.54
Free Cash Flow per Share
12.26 11.94 11.21 11.08
Free Cash Flow
4,702.00 4,571.00 4,283.00 4,238.00
Other line items

Show all line items

Columns are period end dates